Skip to main content
. 2023 Mar 13;11(6):839. doi: 10.3390/healthcare11060839

Table 3.

Effects and heterogeneity for comparisons between studies.

Effects Heterogeneity
Outcome Study Design SAMPLE SIZE SMD (IV, Random, 95%CI) p I2 (%) p
Quality of life Controlled group (n = 4) 139 2.08 [−0.33, 4.49] 0.09 96 <0.00001
Pre/posttest group (n = 5) 74 0.86 [0.06, 1.67] 0.04 79 0.0002
Total (n = 9) 213 1.26 [0.33, 2.20] 0.008 91 <0.00001
Psychological well-being Controlled group (n = 4) 202 1.69 [−0.45, 3.83] 0.12 97 <0.00001
Pre/posttest group (n = 1) 6 0.46 [−0.69, 1.62] 0.43 - -
Total (n = 5) 208 1.40 [−0.32, 3.12] 0.11 96 <0.00001
Depression Controlled group (n = 3) 166 1.17 [−0.35, 2.70] 0.13 95 <0.00001
Pre/posttest group (n = 4) 59 0.42 [0.05, 0.78] 0.03 0 0.82
Total (n = 7) 225 0.70 [−0.03, 1.42] 0.03 85 <0.00001
Anxiety Controlled group (n = 2) 94 0.88 [−0.82, 2.58] 0.31 93 0.0002
Pre/posttest group (n = 1) 5 1.74 [0.16, 3.32] 0.03 - -
Total (n = 3) 99 1.10 [−0.24, 2.45] 0.11 87 0.0004
Trauma-related disorders Controlled group (n = 1) 46 0.14 [−0.46, 0.74] 0.65 - -
Pre/posttest group (n = 3) 123 0.90 [0.52, 1.28] <0.00001 36 0.21
Total (n = 4) 169 0.70 [0.23, 1.17] 0.003 66 0.03
Communication skills Controlled group (n = 3) 86 1.11 [−0.68, 2.90] 0.22 92 <0.00001
Pre/posttest group (n = 1) 5 4.98 [1.91, 8.04] 0.001 - -
Total (n = 4) 91 1.76 [−0.06, 3.57] 0.06 91 <0.00001
Cognitive functioning Controlled group (n = 3) 123 1.58 [0.62, 2.54] 0.001 81 <0.00001
Pre/posttest group (n = 4) 66 3.47 [−1.02, 7.97] 0.13 98 0.006
Total (n = 7) 189 2.50 [0.77, 4.23] 0.005 96 <0.00001
Self-regard Controlled group (n = 2) 92 2.83 [−0.90, 6.56] 0.14 96 <0.00001
Pre/posttest group (n = 3) 123 0.39 [0.14, 0.65] 0.002 0 0.83
Total (n = 5) 215 1.40 [−0.06, 2.86] 0.06 95 <0.00001